Lectures recorded during the annual EPCCS master classes

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

AHA 2017 A lot of variation in BP measurement methods was seen in SPRINT, despite the protocol, but in 3/4 of sites patients were alone at least at some point during the BP reading.

Good BP measurement depends more on appropriate technique than on absence of staff

AHA 2017 In the SPRINT study, BP was not always measured in absence of a physician or nurse. A posthoc survey investigated whether this affected the findings of the study.

Things to consider when aiming to prevent stroke in a patient with AF

EPCCS 2017 Prof. David Fitzmaurice and dr. Geert-Jan Geersing consider the updates in the latest ESC Guidelines on atrial fibrillation that are most relevant to GPs, including which risk scores can help to optimally manage AF, and which drawbacks the scores have.

What can be learned from the latest hypertension trials?

EPCCS 2017 Prof. Richard McManus summarises the results of three large trials that evaluated different intensities of blood pressure management and different blood pressure targets. With prof. Richard Hobbs, he considers what lessons can be learned for primary care.

Heart failure diagnosis and management varies substantially across European countries

EPCCS 2017 Dr. Clare Taylor and dr. Arno Hoes discuss the major changes in the latest ESC HF Guidelines and summarise what they learned from the discussion about HF management in different countries.

How do the latest guideline changes affect management of dyslipidaemia in primary care?

EPCCS 2017 Dr. Frans Rutten and dr. Carlos Brotons summarise the latest updates in the ESC guidelines on dyslipidaemia, relevant for the GP, and summarise the discussion this presentation sparked among the EPCCS audience.

Ingredients of effective strategies to stimulate behaviour change

EPCCS 2017 In their summary of the EPCCS session on behaviour change, dr. Monika Hollander and prof. Christi Deaton highlight which techniques to help patients improve risk behaviour can be employed.

The evidence base for health behaviour changes

Prof. Richard Hobbs (Oxford, UK)  and Prof. Paul Aveyard (Oxford, UK) discuss the evidence base of effectiveness of health behaviour changes and how GPs can best play a role in stimulating a patient to engage in lifestyle modifications to reduce their CV risk. 

Identifying and treating patients with true hypertension

Richard McManus (Oxford, UK) and Monika Hollander (Utrecht, The Netherlands) discuss which blood pressure measurement method is best to identify true hypertension in primary care and how this should be treated.

What is the evidence base for lipid modification in the guidelines updates?

Richard Hobbs (Oxford, UK) and Arno Hoes (Utrecht, The Netherlands) summarise the lively discussion after Hoes' talk on dilemmas in lipid-lowering in primary care.

Heart failure diagnosis and management

EPCCS 2015 Clare Taylor (Birmingham, United Kingdom) questions Frans Rutten (Utrecht, The Netherlands), who gave an update on the evidence base for HF diagnosis and management in the guideline. They discuss how patients with HF can be identified and managed in Primary Care.

EPCCS Annual meeting 2014

E-Learning All lectures September 18, 2014

We should treat lifetime risk

Prof. Arno Hoes – Utrecht, The Netherlands as part of the Plenary Debate: Controversies on CVD risk

We should continue treating on 10 year risk

E-Learning Plenary Debate: Controversies on CVD risk
Dr. Thierry Christiaens, General Practitioner in Ghent (Belgium) and Clinical pharmacologist, Associate professor in the Department of Family Medicine and Primary Health Care Ghent University. Director of the Belgian Centre of Pharmacotherapeutic Information (BCFI/CBIP)

AF-related stroke: beyond the data

E-Learning EPCCS, September 5-6, 2013
Ischaemic stroke related to atrium fibrillation is a preventable disaster. Paul Guyler MD (Southend-on-Sea, UK) provides an overview for general practioners.

The NOACs in SPAF: primary care and beyond

E-Learning EPCCS, September 5-6, 2013
John Eikelboom MD (Ontario, Canada) discusses the evidence supporting guideline recommendations for the use of new oral anticoagulants (NOACs) to prevent stroke in atrial fibrillation (SPAF). 

Beyond the evidence and into clinical practice

E-Learning EPCCS, 5-6 September 2013
Sarah Davis, GP in London, discusses some challenging patient cases: 'beyond the evidence and into the real world'. This presentation was held at the 6th annual EPCCS meeting in London.

What’s new in diabetes care?

E-Learning PCDE lecture

A novel test to diagnose CVD in primary care: what evidence is needed?

Lecture by Professor Arno Hoes, Utrecht, NL at EPCCS annual conference 2013 in London

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...